Search
Search Results
##search.searchResults.foundPlural##
-
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1060PDF: 459HTML: 211 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3265PDF: 564HTML: 630 -
Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts COVID-19 in cancer patients
1128PDF: 747HTML: 205 -
HIV AND LYMPHOMA: FROM EPIDEMIOLOGY TO CLINICAL MANAGEMENT Guest Editors: Mario Luppi and Luca Arcaini
3442PDF: 2121HTML: 351 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
3825PDF: 1438HTML: 9170Untitled: 257Untitled: 162Untitled: 149Untitled: 143Untitled: 163Untitled: 316 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3621PDF: 1207HTML: 3863Untitled: 189Untitled: 240 -
DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE
3549PDF: 1250HTML: 701Figure 2: 422Figure 1: 3088 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2162PDF: 925HTML: 1868 -
ADVANCES IN THE TREATMENT OF MALARIA
2778PDF: 1091HTML: 5976 -
FUNGAL INFECTIONS OF THE EAR IN IMMUNOCOMPROMISED HOST: A REVIEW
3442PDF: 1324HTML: 3675Letter to Editor: 166 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
1968PDF: 1458HTML: 258 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7194PDF: 2368HTML: 1703Table 1.: 183Table 2.: 199Table 3.: 179Table 4.: 178 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2680PDF: 1752HTML: 3631Pellagatti Fig 1: 186Pellagatti Fig. 2: 183 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
901PDF: 1180HTML: 88 -
CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children
1345PDF: 901HTML: 288 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1692PDF: 931HTML: 126 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
1437PDF: 353HTML: 182 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4009PDF: 1194HTML: 1944Table 1: 174 -
-
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1437PDF: 1126HTML: 171 -
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era
1202PDF: 901HTML: 83 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1327PDF: 656HTML: 1067Untitled: 164Untitled: 129Untitled: 113Untitled: 136Untitled: 142 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1616PDF: 623HTML: 2413 -
PROPHYLAXIS OF MALARIA
2952PDF: 989HTML: 17772Figures SChwartz: 145 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3174PDF: 1485HTML: 394 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
927PDF: 511HTML: 7797







